Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings

BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disease causing unpredictable and potentially life-threatening subcutaneous and submucosal edematous attacks. Cinryze® (Shire ViroPharma Inc., Lexington, MA, USA), a nanofiltered C1 inhibitor (C1-INH), is approved in Europe for the treatment,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Arch Allergy Immunol
Main Authors: Aygören-Pürsün, Emel, Soteres, Daniel, Moldovan, Dumitru, Christensen, Jim, Van Leerberghe, Arthur, Hao, James, Schranz, Jennifer, Jacobson, Kraig W., Martinez-Saguer, Inmaculada
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2017
Assuntos:
Basic and Clinical Immunology - Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841133/
https://ncbi.nlm.nih.gov/pubmed/28662509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados